So were are the minutes?
Delay by the FDA? Well they do have a very complex problem. They have either raised the bar for the potancy assay or added a hurdle to insure same potancy of new product. This is setting FDA pollicy.
MSB have recived but disagree that they reflect the meeting. Perhaps somthing may have been left out.
No new information. Would they not announce that fairly soon after they got them? Or is other news very close.
Bad news would need to be releast.
Ann: Mesoblast Type A Meeting with FDA, page-510
-
- There are more pages in this discussion • 65 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Add MSB (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
$1.17 |
Change
0.000(0.00%) |
Mkt cap ! $1.318B | |||
| Open | High | Low | Value | Volume |
| $1.15 | $1.20 | $1.15 | $3.033M | 2.598M |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 14 | 8901 | $1.17 |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| $1.17 | 38361 | 16 |
View Market Depth
| Last trade - 14.25pm 16/07/2024 (20 minute delay) ? |
| MSB (ASX) Chart |